Entering text into the input field will update the search result below

Abbott Laboratories: Organic Growth Will Carry It Through

May 25, 2023 1:31 PM ETAbbott Laboratories (ABT)3 Comments
Waterside Insight profile picture
Waterside Insight


  • Abbott had a visible slowdown in top line and earnings margin starting in 2022 and continued in Q1's data.
  • It is likely to have more persistent weakness in the bottom line in '23 and '24 to show up.
  • The company continued to provide a strong pipeline of product innovation and cross-industry collaboration.
Illinois Drugmaker Under Investigation By State Attorney General

Tim Boyle

Investment Thesis

Abbott Laboratories (NYSE:ABT), although it still has a strong topline, the marginal growth is visibly slowing down, which is also reflected in its operating income and earnings margin. The market has largely caught on to this near-term weakness, judging from the

This article was written by

Waterside Insight profile picture
We are data-oriented investors with over 20 years of investment experience in stocks, fixed income, forex, commodities futures, and options with success. With our unique approach, we provide independent opinions and insights focused on discovering medium-term investment opportunities. Waterside Insight is a wholly-owned subsidiary of RootBanyan Capital Management LLC.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Comments (3)

SuperPac profile picture
Your bearish case gives ABT stock a value of $120 a share.

The actual share price is $100 right now.

The stock has given up all the gains made in the last 3 years. That still is 23X '23 earning estimate. '24 over '23 growth expectations are muted. Any near term catalysts? Doesn't seem so. May be a good time to slowly accumulate.
Thank you for the excellent analysis. Over the long term Abbot has been an incredible wealth generator. Its share price has increased 10x over the past three decades plus spinning off the ABBV behemoth to its shareholders. All the while building market leading businesses in multiple sectors. Its true competitive advantage has been superior management. While there have been the inevitable speed bumps, one could readily expect that future long term performance will also exceed expectations. This has been a remarkably well managed company.

Todd Atwood
Lots of real analysis instead of regurgitation of the public data. Thank you.
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.